Literature DB >> 18085689

Impact of childhood cancer on parental employment and sources of income: a Canadian pilot study.

Heather Limburg1, Amanda K Shaw, Mary L McBride.   

Abstract

BACKGROUND: Loss of income and out of pocket expenses related to childhood cancer care can account for over 25% of a family's total disposable income, adding to the stress of facing a life-threatening disease. The objective of this pilot study was to assess the impact of childhood cancer on employment and sources of income within families. PROCEDURE: A retrospective postal-administered questionnaire was used to collect information from parents of children diagnosed with cancer before 20 years of age between 1990 and 1996 in the province of British Columbia (n = 111).
RESULTS: Among full or part-time employed parents, 64% of mothers and 16% of fathers left their job after their child's diagnosis. The large majority of parents who left their jobs were away for less than 1 year (65% of mothers; 78% of fathers) and nearly all were able to return to the same job if they chose to do so (80% of mothers; 89% of fathers). Parents with children <10 years of age at diagnosis and those with leukemia were most likely to take leave from their jobs. There was considerable change in sources of income between the time of diagnosis and survey with more families relying on employment insurance, social assistance or other financial support at diagnosis. Reliance on sources of income other than salary decreased with time since diagnosis.
CONCLUSIONS: It appears that the diagnosis of childhood cancer may cause an important but short-term impact on the employment and income sources of affected families. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18085689     DOI: 10.1002/pbc.21448

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  18 in total

Review 1.  Economic Burden Associated with Cancer Caregiving.

Authors:  Cathy J Bradley
Journal:  Semin Oncol Nurs       Date:  2019-06-20       Impact factor: 2.315

2.  Cost minimization analysis of two treatment regimens for low-risk rhabdomyosarcoma in children: a report from the Children's Oncology Group.

Authors:  Heidi Russell; J Michael Swint; Lincy Lal; Jane Meza; David Walterhouse; Douglas S Hawkins; M Fatih Okcu
Journal:  Pediatr Blood Cancer       Date:  2014-01-22       Impact factor: 3.167

3.  Unmeasured costs of a child's death: perceived financial burden, work disruptions, and economic coping strategies used by American and Australian families who lost children to cancer.

Authors:  Veronica Dussel; Kira Bona; John A Heath; Joanne M Hilden; Jane C Weeks; Joanne Wolfe
Journal:  J Clin Oncol       Date:  2011-01-04       Impact factor: 44.544

4.  Financial burden of therapy in families with a child with acute lymphoblastic leukemia: report from north India.

Authors:  Nishantadeb Ghatak; Amita Trehan; Deepak Bansal
Journal:  Support Care Cancer       Date:  2015-05-05       Impact factor: 3.603

5.  Rising drug cost impacts on cost-effectiveness of 2 chemotherapy regimens for intermediate-risk rhabdomyosarcoma: A report from the Children's Oncology Group.

Authors:  Heidi V Russell; Yueh-Yun Chi; M Fatih Okcu; M Brooke Bernhardt; Carlos Rodriguez-Galindo; Abha A Gupta; Douglas S Hawkins
Journal:  Cancer       Date:  2021-10-08       Impact factor: 6.860

6.  Family life events in the first year of acute lymphoblastic leukemia therapy: a children's oncology group report.

Authors:  Samantha Lau; Xiaomin Lu; Lyn Balsamo; Meenakshi Devidas; Naomi Winick; Stephen P Hunger; William Carroll; Linda Stork; Kelly Maloney; Nina Kadan-Lottick
Journal:  Pediatr Blood Cancer       Date:  2014-08-30       Impact factor: 3.167

7.  Economic impact of advanced pediatric cancer on families.

Authors:  Kira Bona; Veronica Dussel; Liliana Orellana; Tammy Kang; Russ Geyer; Chris Feudtner; Joanne Wolfe
Journal:  J Pain Symptom Manage       Date:  2013-07-18       Impact factor: 3.612

8.  Excellent Outcomes With Reduced Frequency of Vincristine and Dexamethasone Pulses in Standard-Risk B-Lymphoblastic Leukemia: Results From Children's Oncology Group AALL0932.

Authors:  Anne L Angiolillo; Reuven J Schore; John A Kairalla; Meenakshi Devidas; Karen R Rabin; Patrick Zweidler-McKay; Michael J Borowitz; Brent Wood; Andrew J Carroll; Nyla A Heerema; Mary V Relling; Johann Hitzler; Ashley R Lane; Kelly W Maloney; Cindy Wang; Mylène Bassal; William L Carroll; Naomi J Winick; Elizabeth A Raetz; Mignon L Loh; Stephen P Hunger
Journal:  J Clin Oncol       Date:  2021-01-07       Impact factor: 44.544

9.  Population-Based Newborn Screening for Germline TP53 Variants: Clinical Benefits, Cost-Effectiveness, and Value of Further Research.

Authors:  Natalia Kunst; Natasha K Stout; Grace O'Brien; Kurt D Christensen; Pamela M McMahon; Ann Chen Wu; Lisa R Diller; Jennifer M Yeh
Journal:  J Natl Cancer Inst       Date:  2022-05-09       Impact factor: 11.816

10.  Parental stress when caring for a child with cancer in Jordan: a cross-sectional survey.

Authors:  Rami Masa'Deh; Jacqueline Collier; Carol Hall
Journal:  Health Qual Life Outcomes       Date:  2012-07-28       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.